Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA

Written by ACN Newswire

Wednesday, 1 August 2018, 18:35 HKT/SGT

Hangzhou and Shaoxing, China , Aug 1, 2018 - (ACN Newswire) - Ascletis announced today it has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV) new drug application (NDA). Ravidasvir in combination with Ganovo (RDV/DNV Regimen) is the first all-oral interferon-free HCV regimen developed by a domestic company in China. Phase II/III clinical trial has shown that RDV/DNV Regimen demonstrated a cure rate of 99 % ( SVR12) with a short treatment duration of 12 weeks in genotype 1 patients. In patients with baseline NS5A resistance mutations, RDV/DNV Regimen demonstrated a cure rate of 100% (SVR12).

"Ascletis was successfully listed this morning on Hong Kong Exchange as the first ever pre-revenue biotech. The NDA for our all-oral HCV regimen was accepted by CFDA in the afternoon." Jinzi J. Wu, Ph.D., Ascletis' founder, President and CEO, commented, "Two significant accomplishments on the same day reflect our unremitting effort to provide affordable and effective HCV cures to the patients and to fulfill our commitment to the investors."

Ganovo Regimen, Ascletis' first breakthrough HCV regimen, was approved on June 8 and launched on June 27, 19 days after the approval. The acceptance of the NDA for its all-oral HCV regimen enables Ascletis soon to provide two HCV treatment options for Chinese patients, strengthening its leading position in China's HCV field.

Topic: Press release summarySectors: Daily Finance, Daily News, BioTech ^[1]^[2]^[3] http://www.acnnewswire.com From the Asia Corporate News Network

References

^{^} Daily Finance (www.acnnewswire.com)
^{^} Daily News (www.acnnewswire.com)
^{^} BioTech (www.acnnewswire.com)

Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA

References

AI is transforming cybersecurity. Is your training up to date?

Scammers won’t take a break over Christmas. Here’s how to make a plan with your family to stay safe

Could Settlers of Catan make you a better strategist?

Don’t drive the sleigh on your own: 5 tested management tips for surviving Christmas like a boss

How Does Branding Affect Business Growth?

Inequality alone doesn’t cause civil unrest – but internet access adds the crucial spark

Traditions of Rural Bali at Villa Sabana

Essential Reasons to Opt for a Professional Valuation Before Selling Your Commercial Property

Office Odyssey: 5 Tips for Successfully Maneuvering Your Business Move

Why Australia banning live animal exports may be a net loss for animal welfare

Bridging the Strategy-Execution Gap: 4 key approaches for businesses to deliver successful strategies

From Check-in to Touchdown: How AI and smarter systems are transforming the travel industry

Online Christmas shoppers fund climate and biodiversity projects via HealthPost's Click Sphere for Good initiative

US landmark settlement protects SMEs, highlighting flaws in the RBA's proposed blanket card surcharging ban for Australia

Thryv Australia named Employer of Choice for third consecutive year at Australian Business Awards

RogersDigital.com Announces the Launch of TheBulletin.au, a Destination for Business, Policy and Financial Insight

Controlling business spend is helping finance leaders to forecast with confidence

How Contiki is Redefining Travel for Young Adventurers

Navigating the Cosmetic Advertising Crackdown Before September Guidelines Hit

Defining Actionable AI for Australian IT Efficiency and Security